An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies.

Depending mostly on voluntarily sent spontaneous reports, pharmacovigilance studies are hampered by low quantity and quality of patient data. Our objective is to improve postmarket safety studies by enabling safety analysts to seamlessly access a wide range of EHR sources for collecting deidentified...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2016; pp. 1 - 19
Autores principales: Yuksel, Mustafa, Gonul, Suat, Laleci Erturkmen, Gokce Banu, Sinaci, Ali Anil, Invernizzi, Paolo, Facchinetti, Sara, Migliavacca, Andrea, Bergvall, Tomas, Depraetere, Kristof, De Roo, Jos
Formato: computer program research tables/charts Journal Article
Publicado: Wiley-Blackwell 3/31/2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=114142329&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 114142329
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 3/31/2016
      vid: 2016
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        114142329
        114142329
        114142329
        10.1155/2016/6741418
        114142329
      ppf: 1
      ppct: 18
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies.
      aug:
        au:
          Yuksel, Mustafa
          Gonul, Suat
          Laleci Erturkmen, Gokce Banu
          Sinaci, Ali Anil
          Invernizzi, Paolo
          Facchinetti, Sara
          Migliavacca, Andrea
          Bergvall, Tomas
          Depraetere, Kristof
          De Roo, Jos
        affil: SRDC Software Research & Development and Consultancy Ltd., 06800 Ankara, Turkey
      sug:
        subj:
          Electronic Health Records
          Pharmacovigilance
          Adverse Drug Event
          Safety
          Validity
          Software Design
          Myocardial Infarction Chemically Induced
          Nifedipine Administration and Dosage
          Pancreatitis Chemically Induced
          Ramipril Administration and Dosage
          Men's Health
          Amiodarone Administration and Dosage
          Ramipril Adverse Effects
          Amiodarone Adverse Effects
          Antiarrhythmia Agents Administration and Dosage
          Pancreatitis Risk Factors
          Nomenclature
          Hemorrhage Classification
          International Classification of Diseases
          Comparative Studies
          Descriptive Statistics
          Funding Source
      ab: Depending mostly on voluntarily sent spontaneous reports, pharmacovigilance studies are hampered by low quantity and quality of patient data. Our objective is to improve postmarket safety studies by enabling safety analysts to seamlessly access a wide range of EHR sources for collecting deidentified medical data sets of selected patient populations and tracing the reported incidents back to original EHRs. We have developed an ontological framework where EHR sources and target clinical research systems can continue using their own local data models, interfaces, and terminology systems, while structural interoperability and Semantic Interoperability are handled through rule-based reasoning on formal representations of different models and terminology systems maintained in the SALUS Semantic Resource Set. SALUS Common Information Model at the core of this set acts as the common mediator. We demonstrate the capabilities of our framework through one of the SALUS safety analysis tools, namely, the Case Series Characterization Tool, which have been deployed on top of regional EHR Data Warehouse of the Lombardy Region containing about 1 billion records from 16 million patients and validated by several pharmacovigilance researchers with real-life cases. The results confirm significant improvements in signal detection and evaluation compared to traditional methods with the missing background information.
      pubtype: Academic Journal
      doctype:
        computer program
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N